Skip to main content
Indian Journal of Psychiatry logoLink to Indian Journal of Psychiatry
. 2023 Dec 11;65(12):1249–1253. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_825_23

Panic disorder: Epidemiology, disability, and treatment gap from nationally representative general population of India

Pavithra Jayasankar 1, Suhas Satish 1, Hari Hara Suchandra 1, Narayana Manjunatha 1,✉, Girish N Rao 2, Gopalkrishna Gururaj 3, Mathew Varghese 1, Vivek Benegal 4; NMHS National Collaborators Group
PMCID: PMC10826862  PMID: 38298880

Abstract

Introduction:

Panic disorder (PD) is one of the most common and debilitating anxiety disorder. Individuals with PD seek frequent healthcare and emergency services leading to frequent work absenteeism and economic burden. However, its prevalence patterns in the Indian context are poorly understood. Hence, this article discusses the epidemiology, disability, and treatment gap from India's National Mental Health Survey 2016.

Materials and Methods:

National Mental Health Survey 2016 was a nationally representative epidemiological survey of adult respondents from 12 states of India. Mini International Neuropsychiatric Interview 6.0.0 is used to diagnose psychiatric disorders. Sheehan disability scale was used to assess the disability. The current weighted prevalence of PD was estimated. Association between PD and its sociodemographic correlates was done using Firth penalized logistic regression. The treatment gap and disability in PD were also calculated.

Results:

The lifetime and current weighted prevalence of PD was 0.5% (95% confidence interval 0.49-0.52) and 0.3% (95% confidence interval 0.28-0.41), respectively. The male gender and unemployed have significantly lesser odds with current PD. The elderly, Urban metro, and the married/separated group have significantly higher odds with current PD. The most common comorbid psychiatric disorder is agoraphobia (42.3%) and depression (30.9%) followed by Generalized Anxiety Disorder (10%). Among respondents with current PD in the past 1 month across three domains, around 80% had a disability of any severity and 20%-25% had marked disability. The overall treatment gap of current PD is 71.7%.

Conclusion:

It is the first study reporting prevalence from a nationally representative sample from the general population of India. The survey has shed light on the epidemiology and the challenges faced by those with PD which emphasizes the urgency of bridging the treatment gap. These findings are paramount to the development of more inclusive and effective mental health policies and interventions to tackle the current burden due to PD.

Keywords: Epidemiology, India, national mental health survey, panic disorder, prevalence

INTRODUCTION

Panic disorder (PD) is one of the common anxiety disorders characterized by recurrent intense anxiety states associated with severe social and health consequences.[1,2] The disability in PD is comparable to other noncommunicable diseases such as diabetes.[3] Individuals with PD also have poor social functioning,[4] heightened possibility of suicide attempts,[5] and substance use.[6] Also, there has been recent evidence of considerable disability associated with sub-threshold panic attacks.[7,8] Individuals suffering from PD as well as subthreshold panic attacks often have comorbid psychiatric disorders[9,10] which further adds to the disability. Hence, individuals with PD display increased healthcare utilization services and emergency care consultation leading to financial strain and work absenteeism.[11,12,13,14]

Despite the huge burden associated with PD, its prevalence and its correlates are poorly understood in the Indian context. A comprehensive grasp of its epidemiology fosters greater awareness among healthcare providers and the public, reducing stigma and improving outcomes.

Hence, this article delves into the findings of the epidemiology of PD, the burden of disability it imposes, and the estimation of the treatment gap from a first nationally representative sample from the general population of Bharat (India), that is, National Mental Health Survey (NMHS) 2016.

MATERIALS AND METHODS

Sample

NMHS 2016 was a nationally representative household survey of 34,802 respondents aged 18 years and more from 12 states of India. The study design of the NMHS was a multistage, stratified, random cluster sampling technique, with random selection based on Probability Proportion to Size at each stage. Face-to-face interviews were conducted by trained field workers with an individual response rate of 88%. Quality assurance was done using various measures such as certification of training for field data collectors, regular data checks, 5% validation re-interviews, and periodic monitoring of activities. Detailed methodology is available elsewhere.[15,16,17,18]

Assessment of panic disorder

PD was assessed using Mini International Neuropsychiatric Interview (MINI) 6.0.0.[19] The MINI is a structured diagnostic interview instrument for screening and diagnosing psychiatric disorders as per Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, (DSM-IV TR) and International Classification of Diseases 10th revision (ICD-10). PD was defined as the presence of four or more symptoms of uncued panic attacks not due to substance use or general medical condition accompanied by 1 month or more of persistent concern about having another attack or worries about consequences of attacks or significant change in behavior because of attacks. Both current and lifetime prevalence were estimated for PD with current prevalence defined as the presence of symptoms in the past 1 month.

Comorbid psychiatric disorders

The proportion of other psychiatric disorders is diagnosed using MINI was estimated among diagnosed PD. Suicidality was assessed using a set of questions in MINI and interpreted as mild, moderate, and high suicidality. We calculated total suicidality by adding all three subgroups. For the sake of uniformity, current estimates were used in all comorbid psychiatric disorders.

Disability estimates

Disability among diagnosed PD was assessed using the Sheehan disability scale.[20] The respondents were asked to rate their impairment in work, social, and family life using a 10-point visual analog scale. The numbers obtained were re-grouped into five categories: No disability, mild (score 1-3), moderate (score 4-6), marked (score 7-9), and extreme disability (score 10).

Treatment gap

Respondents with PD were asked, “whether they are receiving any treatment from a formal health care provider”. The treatment gap was estimated from the proportion of respondents with PD not receiving treatment. Also, details regarding duration of treatment, duration of illness, and time gap between the onset of illness to consultation were collected.

Statistical analysis

To ensure that findings are representative of the Indian population, all estimates were weighted to account for unequal probability of selection and nonresponse rates. Descriptive analysis was used to describe the current weighted prevalence of PD, its sociodemographic characteristics, comorbidity with other psychiatric disorders, disability, and treatment gap. Modelling the data for binomial outcomes (persons with PD and without PD) was essential to generate an odds ratio from logistic regression analysis. Since the number of persons with PD was disproportionate to persons without, it led to the problem of statistical separation or monotone likelihood. Hence, Firth bias reduced logistic regression[21,22] was chosen in concurrence with published literature. This statistical procedure reduces first-order bias in maximum likelihood estimates of beta, and small sample size and provides finite, consistent estimates. P < .05 was kept statistically significant. R software and IBM Statistical Package for Social Sciences (SPSS) version 28 was used to perform statistical analysis.[23]

RESULTS

Prevalence

The weighted estimates of the current and lifetime prevalence of PD were 0.3% (95% confidence interval [CI] 0.28-0.41) and 0.5% (95% CI 0.49-0.52), respectively.

Sociodemographic correlates

Among sociodemographic correlates [Table 1], the adjusted odds ratio (Firth bias reduced logistic regression) associated with being elderly was significantly higher among the PD group. Respondents who were male and unemployed had reduced odds among the PD group. Among marital status, married and separated/widowed had significantly increased odds in PD's current group. Urban metro had significantly increased odds among PD's current group.

Table 1.

Multiple logistic regression (Firth) of sociodemographic correlates with PD (current)

Adjusted OR 95% CI P
Gender
  Male 0.48 0.3-0.7 <0.001
  Female (ref)
Age
  18-29 (ref)
  30-39 1.4 0.8-2.6 0.2
  40-49 1.3 0.7-2.5 0.3
  50-59 1.2 0.6-2.5 0.4
  > 60 1.8 1.0-3.5 0.04
Education
  Illiterate (ref)
  Primary 1.4 0.8-2.3 0.1
  Secondary 0.8 0.4-1.6 0.6
  High school 1.0 0.5-1.8 0.8
  Pre-University 1.3 0.6-2.6 0.4
  Graduate 0.8 0.3-1.7 0.6
Occupation
  Employed (ref)
  Unemployed 0.5 0.3-0.8 0.01
Marital status
  Never married (ref)
  Married/widowed/separated 3.8 1.5-12 0.002
Residence
  Rural (ref)
  Urban nonmetro 0.8 0.4-1.3 0.48
  Urban metro 2.3 1.4-3.5 <0.001

*CI, Confidence Interval; OR, Odds Ratio

Comorbid psychiatric disorders

Among comorbid psychiatric disorders, agoraphobia (42.3%), depression (30.9%), and Generalized Anxiety Disorder (GAD) (10%) were highly prevalent among respondents with PD with adjusted odds of 14.6, 3.1, and 5.8, respectively. 6.8% of respondents with PD had post-traumatic stress disorder with an adjusted odds of 3.42.8% of respondents with PD had suicidality of any severity with an adjusted odd of 4.3. Other disorders such as alcohol use disorder, psychosis, bipolar disorder, social phobia, and obsesseive compulsive disorder did not attain statistical significance.

Disability estimates

Seventy seven percent respondents with PD had disability at work of any severity, while around 80% had disability at social and family life. Of PD group with any disability, the rates of severity varied from 44.7%-51.7% in mild severity to 5.7%-9.6% in extreme disability across three domains [Table 2].

Table 2.

Disability estimates of respondents with PD (current)

Self-reported disability n (%) No disability Any disability*
Mild Moderate Marked Extreme
Disability at work 26[23] 45 (51.7) 24 (27.6) 13 (14.9) 5 (5.7)
Disability in social life 23 (20.4) 43 (47.8) 25 (27.8) 16 (17.8) 6 (6.7)
Disability at family life 19 (16.8) 42 (44.7) 28 (29.8) 15[16] 9 (9.6)

*Disability was regrouped as no and any disability. Of any disability, % in each severity was presented

Treatment gap

The treatment gap of respondents in PD group was 71.7%. The treatment gap was more among females (74.4%) than males (66.7%). Among residents, rural areas had a higher treatment gap (74.3%) followed by urban nonmetros (70.6%) compared to urban metros (65.5%).

DISCUSSION

In this nationally representative sample of the Indian population, the lifetime and current weighted prevalence of PD was 0.5% (95% CI 0.49-0.52) and 0.3% (95% CI 0.28-0.41), respectively. The limited symptom panic attacks were equally prevalent as current PD.

Previous meta-analysis on Indian epidemiological studies has studied only GAD and phobia as a part of anxiety neurosis, hence we do not have a comparison with those studies.[24,25] The 12-month prevalence rate of PD was 0.52% in the Indian WMHS study[26] which is similar to our lifetime prevalence rates.

Other recent Western studies have showed that the lifetime prevalence of PD is around 1.7%-1.9%.[27,28] Previous Western epidemiological studies such as The National Comorbidity Survey Replication (NCS-R) had estimated lifetime prevalence of PD even higher (3.7% for PD).[29] However, our estimates were closer to lifetime estimates of PD from China and Japan mental health surveys.[30,31] The cross-national epidemiology of PD also has shown current prevalence of PD between 0.5% and 1.2%[32,33] with higher prevalence in high-income countries. Our findings are in line with the estimates from low-income countries in WMHS surveys.[34]

Comorbid psychiatric disorders

The most common comorbidity in PD was agoraphobia (42.3%) followed by depression (30.9%). Even other Western studies have found a consistently close association of PD with agoraphobia.[35] Hence, it becomes important to screen the patients with PD for the presence of agoraphobia. However, due to the cross-sectional nature of the study, it is not possible to comment on the trajectory of PD. A substantial group of patients with PD (30%) had depression. Around 10% of respondents with PD had GAD. A similar trend has been noticed in other epidemiological studies.[36] The estimates on other comorbid anxiety disorders in respondents with PD point toward the significance of comorbidity among anxiety disorders.

Disability in PD

Around 77%-83% of respondents with PD had a disability of any severity. Of which, around 20%-25% had marked and extreme disability. The disability calculated was from the total PD (current) group which also includes comorbid psychiatric disorders as it is the most seen scenario in the community. Other studies have also demonstrated disability in PD leads to poor quality of life.[37] These estimates highlight the need for public health policies and interventions to focus on early detection and treatment of PD.

Treatment gap in PD

Around 71% of respondents with PD did not receive any form of treatment. Females in rural areas had an even larger treatment gap. Despite efforts to provide care, a huge treatment gap exists across all areas and disorders.[38] More novel and feasible strategies have to be implemented to close this treatment gap and hence reduction in disability.[39]

CONCLUSION

This study was the first epidemiological study of a nationally representative sample in India exploring the prevalence, comorbidity, disability, and demographic correlates for PD. According to our observation, PD is quite common in the general adult population with substantial comorbidity rates. This points toward the scope of further research to illuminate the pathway of PD. The huge treatment gap could be controlled with the development of more efficient diagnostic and treatment plans where the patients will be entitled to timely and to the point care.

Financial support and sponsorship

The National Mental Health Survey (NMHS) was funded by the Ministry of Health and Family Welfare, Government of India and were implemented and co-ordinated by National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, INDIA in collaboration with state partners. NMHS phase 1 (2015-2016) was undertaken in 12 states of India across the six regions and interviewed 39,532 individuals (http://indianmhs.nimhans.ac.in). Funder had no role in implementation, data acquisition, data analysis, and interpretation and write up of the paper.

Conflicts of interest

There are no conflicts of interest.

Acknowledgments

NMHS National Collaborators Group include Pathak K, Singh LK, Mehta RY, Ram D, Shibukumar TM, Kokane A, Lenin Singh RK, Chavan BS, Sharma P, Ramasubramanian C, Dalal PK, Saha PK, Deuri SP, Giri AK, Kavishvar AB, Sinha VK, Thavody J, Chatterji R, Akoijam BS, Das S, Kashyap A, Ragavan VS, Singh SK, Misra R and investigators as listed in the report: “National Mental Health Survey of India, 2015-16: Prevalence, Patterns and Outcomes” available at https://indianmhs.nimhans.ac.in/phase1/Docs/Report2.pdf.

The authors would also like to sincerely thank Professor David V Sheehan, Distinguished University Health Professor Emeritus at the College of Medicine, University of South Florida, USA, for his guidance and valuable inputs for the smooth, scientific, and efficient conduct of the survey.

REFERENCES

  • 1.Davidoff J, Christensen S, Khalili DN, Nguyen J, IsHak WW. Quality of life in panic disorder: Looking beyond symptom remission. Qual Life Res. 2012;21:945–59. doi: 10.1007/s11136-011-0020-7. [DOI] [PubMed] [Google Scholar]
  • 2.Manjunatha N, Ram D. Panic disorder in general medical practice- A narrative review. J Family Med Prim Care. 2022;11:861–9. doi: 10.4103/jfmpc.jfmpc_888_21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rubin HC, Rapaport MH, Levine B, Gladsjo JK, Rabin A, Auerbach M, et al. Quality of well being in panic disorder: The assessment of psychiatric and general disability. J Affect Disord. 2000;57:217–21. doi: 10.1016/s0165-0327(99)00030-0. [DOI] [PubMed] [Google Scholar]
  • 4.Carrera M, Herrán A, Ayuso-Mateos JL, Sierra-Biddle D, Ramírez ML, Ayestarán A, et al. Quality of life in early phases of panic disorder: Predictive factors. J Affect Disord. 2006;94:127–34. doi: 10.1016/j.jad.2006.03.006. [DOI] [PubMed] [Google Scholar]
  • 5.Nepon J, Belik SL, Bolton J, Sareen J. The relationship between anxiety disorders and suicide attempts: Findings from the national epidemiologic survey on alcohol and related conditions. Depress Anxiety. 2010;27:791–8. doi: 10.1002/da.20674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Smith JP, Book SW. Anxiety and substance use disorders: A review. Psychiatr Times. 2008;25:19–23. [PMC free article] [PubMed] [Google Scholar]
  • 7.Oral E, Aydin N, Gulec M, Oral M. Panic disorder and subthreshold panic in the light of comorbidity: A follow-up study. Compr Psychiatry. 2012;53:988–94. doi: 10.1016/j.comppsych.2012.01.009. [DOI] [PubMed] [Google Scholar]
  • 8.Batelaan N, De Graaf R, Van Balkom A, Vollebergh W, Beekman A. Thresholds for health and thresholds for illness: Panic disorder versus subthreshold panic disorder. Psychol Med. 2007;37:247–56. doi: 10.1017/S0033291706009007. [DOI] [PubMed] [Google Scholar]
  • 9.Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. Am J Psychiatry. 2005;162:1179–87. doi: 10.1176/appi.ajp.162.6.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Liaugaudaite V, Podlipskyte A, Mickuviene N. Comorbidity of depression and panic disorder affects suicide attempts in patients with mood disorders. Eur Neuropsychopharmacol. 2017:27. [Google Scholar]
  • 11.Lara Muñoz MDC, Medina-Mora ME, Borges G, Zambrano J. Social cost of mental disorders: Disability and work days lost. Results from the Mexican survey of psychiatric epidemiology. Salud Ment. 2007:30. [Google Scholar]
  • 12.Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med. 1997;27:861–73. doi: 10.1017/s0033291797004807. [DOI] [PubMed] [Google Scholar]
  • 13.Kondapura MB, Manjunatha N, Nagaraj AKM, Praharaj SK, Kumar CN, Math SB, et al. Work productivity (absenteeism and presenteeism) in persons with common mental disorders: An observational study from South India. Indian J Psychiatry. 2023;65:412–8. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_730_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kondapura MB, Manjunatha N, Nagaraj AKM, Praharaj SK, Kumar CN, Math SB, et al. Cost of illness analysis of common mental disorders: A study from an Indian academic tertiary care hospital. Indian J Psychol Med. 2023;45:519–25. doi: 10.1177/02537176221108867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pradeep BS, Gururaj G, Varghese M, Benegal V, Rao GN, Sukumar GM, et al. National mental health survey of India, 2016-Rationale, design and methods. PLoS One. 2018;13:e0205096. doi: 10.1371/journal.pone.0205096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gautham MS, Gururaj G, Varghese M, Benegal V, Rao GN, Kokane A, et al. The national mental health survey of India (2016): Prevalence, socio-demographic correlates and treatment gap of mental morbidity. Int J Soc Psychiatry. 2020;66:361–72. doi: 10.1177/0020764020907941. [DOI] [PubMed] [Google Scholar]
  • 17.Arvind BA, Gururaj G, Loganathan S, Amudhan S, Varghese M, Benegal V, et al. Prevalence and socioeconomic impact of depressive disorders in India: Multisite population-based cross-sectional study. BMJ Open. 2019;9:e027250. doi: 10.1136/bmjopen-2018-027250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.NMHS Collaborators National mental health survey of India, 2015-16: Summary. Natl Ment Heal Surv India. 2016. Available from: http://www.nimhans.ac.in/sites/default/files/u197/National Mental Health Survey -2015-16 Summary_0.pdf .
  • 19.Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, Janavs J, Dunbar GC. The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European psychiatry. 1997;12:224–31. [Google Scholar]
  • 20.DVRush AS, Pincus H, First M. Sheehan disability scale. Handb Psychiatr Meas. 2000 [Google Scholar]
  • 21.Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27–38. [Google Scholar]
  • 22.Suhas S, Manjunatha N, Kumar CN, Benegal V, Rao GN, Varghese M, et al. Firth's penalized logistic regression: A superior approach for analysis of data from India's National Mental Health Survey, 2016. Indian J Psychiatry. 2023;65:1208–13. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_827_23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.IBM Corp . New York: IBM software business analytics; 2020. IBM SPSS statistics for Macintosh, version 28.0. [Google Scholar]
  • 24.Ganguli HC. Epidemiological findings on prevalence of mental disorders in India. Indian J Psychiatry. 2000;42:14–20. [PMC free article] [PubMed] [Google Scholar]
  • 25.Reddy VM, Chandrashekar CR. Prevalence of mental and behavioural disorders in India: A meta-analysis. Indian J Psychiatry. 1998;40:149–57. [PMC free article] [PubMed] [Google Scholar]
  • 26.Sagar R, Pattanayak RD, Chandrasekaran R, Chaudhury PK, Deswal BS, Lenin Singh RK, et al. Twelve-month prevalence and treatment gap for common mental disorders: Findings from a large-scale epidemiological survey in India. Indian J Psychiatry. 2017;59:46–55. doi: 10.4103/psychiatry.IndianJPsychiatry_333_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Politis S, Bellos S, Hadjulis M, Gournellis R, Petrikis P, Ploumpidis D, et al. Epidemiology of panic disorder and subthreshold panic symptoms in the Greek general population. Psychiatriki. 2020;31:201–15. doi: 10.22365/jpsych.2020.313.201. [DOI] [PubMed] [Google Scholar]
  • 28.Skapinakis P, Lewis G, Davies S, Brugha T, Prince M, Singleton N. Panic disorder and subthreshold panic in the UK general population: Epidemiology, comorbidity and functional limitation. Eur Psychiatry. 2011;26:354–62. doi: 10.1016/j.eurpsy.2010.06.004. [DOI] [PubMed] [Google Scholar]
  • 29.Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the national comorbidity survey replication. Arch Gen Psychiatry. 2006;63:415–24. doi: 10.1001/archpsyc.63.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: A cross-sectional epidemiological study. Lancet Psychiatry. 2019;6:211–24. doi: 10.1016/S2215-0366(18)30511-X. [DOI] [PubMed] [Google Scholar]
  • 31.Ishikawa H, Kawakami N, Kessler RC, World Mental Health Japan Survey Collaborators Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: Results from the final dataset of world mental health Japan survey. Epidemiol Psychiatr Sci. 2016;25:217–29. doi: 10.1017/S2045796015000566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry. 1997;54:305–9. doi: 10.1001/archpsyc.1997.01830160021003. [DOI] [PubMed] [Google Scholar]
  • 33.de Jonge P, Roest AM, Lim CC, Florescu SE, Bromet EJ, Stein DJ, et al. Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depress Anxiety. 2016;33:1155–77. doi: 10.1002/da.22572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Goisman RM, Goldenberg I, Vasile RG, Keller MB. Comorbidity of anxiety disorders in a multicenter anxiety study. Compr Psychiatry. 1995;36:303–11. doi: 10.1016/s0010-440x(95)90076-4. [DOI] [PubMed] [Google Scholar]
  • 35.Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE. Lifetime panic-depression comorbidity in the national comorbidity survey. Arch Gen Psychiatry. 1998;55:801–8. doi: 10.1001/archpsyc.55.9.801. [DOI] [PubMed] [Google Scholar]
  • 36.Brown TA, Barlow DH. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. J Consult Clin Psychol. 1992;60:835–44. doi: 10.1037//0022-006x.60.6.835. [DOI] [PubMed] [Google Scholar]
  • 37.Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984–92. doi: 10.1001/archpsyc.1989.01810110026004. [DOI] [PubMed] [Google Scholar]
  • 38.Singh OP. Closing treatment gap of mental disorders in India: Opportunity in new competency-based medical council of India curriculum. Indian J Psychiatry. 2018;60:375–6. doi: 10.4103/psychiatry.IndianJPsychiatry_458_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pahuja E, Kumar TS, Uzzafar F, Manjunatha N, Kumar CN, Gupta R, et al. An impact of a digitally driven primary care psychiatry program on the integration of psychiatric care in the general practice of primary care doctors. Indian J Psychiatry. 2020;62:690–6. doi: 10.4103/psychiatry.IndianJPsychiatry_324_20. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES